126 related articles for article (PubMed ID: 16895657)
1. New approaches to the therapy of HSV infections.
Whitley R
Herpes; 2006 Aug; 13(2):53-5. PubMed ID: 16895657
[TBL] [Abstract][Full Text] [Related]
2. Treatment of common cutaneous herpes simplex virus infections.
Emmert DH
Am Fam Physician; 2000 Mar; 61(6):1697-706, 1708. PubMed ID: 10750877
[TBL] [Abstract][Full Text] [Related]
3. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
[TBL] [Abstract][Full Text] [Related]
4. Famciclovir as antiviral prophylaxis in laser resurfacing procedures.
Wall SH; Ramey SJ; Wall F
Plast Reconstr Surg; 1999 Sep; 104(4):1103-8; discussion 1109. PubMed ID: 10654754
[TBL] [Abstract][Full Text] [Related]
5. Single-dose famciclovir for the treatment of herpes labialis.
Hull C; Spruance S; Tyring S; Hamed K
Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
[TBL] [Abstract][Full Text] [Related]
6. Famciclovir for the treatment of recurrent genital and labial herpes lesions.
Langley RG
Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):5-7. PubMed ID: 16408140
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus prophylaxis with famciclovir in patients undergoing aesthetic facial CO2 laser resurfacing.
Bisaccia E; Scarborough D
Cutis; 2003 Oct; 72(4):327-8. PubMed ID: 14604087
[TBL] [Abstract][Full Text] [Related]
8. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
[TBL] [Abstract][Full Text] [Related]
10. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
Alster TS; Nanni CA
Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
[TBL] [Abstract][Full Text] [Related]
11. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
[TBL] [Abstract][Full Text] [Related]
12. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
Leone P; Warren T; Hamed K; Fife K; Wald A
Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
14. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
Spruance SL; Bodsworth N; Resnick H; Conant M; Oeuvray C; Gao J; Hamed K
J Am Acad Dermatol; 2006 Jul; 55(1):47-53. PubMed ID: 16781291
[TBL] [Abstract][Full Text] [Related]
15. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
[TBL] [Abstract][Full Text] [Related]
16. Famciclovir safe and effective for herpes.
AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
[No Abstract] [Full Text] [Related]
17. Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
Bartlett BL; Tyring SK; Fife K; Gnann JW; Hadala JT; Kianifard F; Berber E
J Clin Virol; 2008 Oct; 43(2):190-5. PubMed ID: 18621575
[TBL] [Abstract][Full Text] [Related]
18. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
[TBL] [Abstract][Full Text] [Related]
19. The continuing evolution of antiviral therapy for recurrent genital herpes: 1-day patient-initiated treatment with famciclovir.
Aoki FY
Herpes; 2007 Dec; 14(3):62-5. PubMed ID: 18371288
[TBL] [Abstract][Full Text] [Related]
20. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Biswas S; Jennens L; Field HJ
Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
